Navigation Links
Miracle Treatment for Burn Scars as Seen on Today Show Will Also Be Featured on The Insider Tonight

NEW YORK, May 28 /PRNewswire/ -- Following the feature of the UltraPulse CO2 fractional laser as a Miracle Treatment for Burn Scars on The Today Show, The Insider will also be featuring the treatment tonight, check your local listings for the time.

Chandra, Jordan and Trae Berns were interviewed today by The Insider. The interview focused on how and when they got their burns they have lived with for 20 years. The girls also discussed their journey through the treatment process with Dr. Jill Waibel, the treating physician. Specifically, they discussed how the Lumenis UltraPulse Laser has helped to minimize both the unwanted color and roughness of their scars. Lastly, they expressed their happiness in the results of the treatments thus far and look forward to additional treatments and results in the next 3 months.

Dr. Jill Waibel was also interviewed for the segment, in which she discussed the fractional treatment she performed on the girls using the Lumenis laser. Specifically, Dr. Waibel talked about the TotalFX, ActiveFX and DeepFX treatments that were used on the girl's burn scars.

Lumenis pioneered skin resurfacing over 18 years ago with its C02 lasers. The Lumenis UltraPulse laser system has FDA clearance for more than 34 indications and is referenced in excess of 90 peer-reviewed publications. Although frequently used for aesthetic applications, the UltraPulse offers 240 watts of power and microsecond pulses which combined provide a broad canvas from which other treatments in cutaneous surgical and aesthetic applications can be provided.

The entire story of the Berns triplets and their treatments using the UltraPulse Fractional CO2 laser can be found at

About Lumenis

Lumenis Ltd,. a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto

    Contacts: Charly Rok                  Michelle Maydan
              Lippe Taylor                Director of Corporate Communications
              Office: 212-598-4400 x155   Lumenis
              Cell:  917-912-2863         Toll-free: 1-866-569-0597
          Office: +972-4-959-9004

Lumenis(R) is a registered trademark of Lumenis Ltd.

UltraPulse(R) is a trademark of Lumenis Ltd.

Certain statements and information in this press release may be deemed to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements are often characterized by the use of forward-looking terminology such as "may," "will," "expect," "anticipate," "estimate," "continue," "believe," "should," "intend," "project" or other similar words, but are not the only way these statements are identified. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements may be found in our most recent Annual Report on Form 20-F, including the section therein entitled "Risk Factors", as well in our reports on Form 6-K, filed with the Securities and Exchange Commission.

SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
2. Childrens Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection
3. Worlds Miracle Baby Turns One
4. Sharing Miracles Television Program Extends Reach Across America: First Episode Features Former White House Press Secretary Tony Snow
5. Round Table Family Charities Raises $350,000 for Childrens Miracle Network
6. Cranberries really are a miracle cure for women
7. Sharing Miracles Television Program to Feature North Carolina State Womens Basketball Coach Kay Yow
8. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner
9. Sharing Miracles Television Program to Feature Emmy Award-Winning Actor Joey Pantoliano
10. Press Preview to Unveil Miracle Manny
11. The Miracle of Funding by State and Local Pension Plans
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... The recently published 32nd ... System (NPDS) reveals that in 2014, someone called a poison center about every ... of which were human exposure cases. , The American Association of Poison Control ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... promoting breast and prostate cancer education and prevention—is joining forces with the award-winning ... philanthropy and Hollywood elegance on December 7, 2015 at the Union League of ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... Reports magazine, quoted Michael Hansen, Ph.D., a senior scientist at Consumer Reports as ... more so for a child’s exposure limits. , The original Nov 2015 CR ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., ... womb. "My last baby had high blood pressure due to loud noises," she said, ... their babies from noise pollution as well as radio waves and microwaves." , The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015  PTS Diagnostics, the U.S.-based manufacturer ... analyzers, A1CNow ® systems, and PTS Detect™ ... of patents that will propel the company into the ... Europe . The technology is a ... those on smartphones and tablets, and uses test strip ...
(Date:11/30/2015)... , Nov. 30, 2015 Oramed Pharmaceuticals ... focused on the development of oral drug delivery systems, ... agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of Technologies ... oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed at ...
(Date:11/30/2015)... , Nov. 30, 2015 Cumberland Pharmaceuticals (CPIX), today ... live at on December 3, 2015. TIME: ... TIME: 3:15p.m. ET LINK: --> ... --> ... where investors are invited to ask the company questions in ...
Breaking Medicine Technology: